Author

A. Madrigal

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 2 Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 3 Approach:statistical model· 3 Research Focus:cell type annotation· 2 Research Focus:differential expression· 2 Research Focus:gene regulatory network inference· 2 Organism:mouse· 2 Approach:experimental assay· 1 Organism:human· 1

Frequent Co-Authors

F. Ay· 2 shared P. Vijayanand· 2 shared A. Alzetani· 1 shared A. Burban· 1 shared A. Hernandez-Corchado· 1 shared A. Jahani-Asl· 1 shared A. P. Ganesan· 1 shared A. Sharanek· 1 shared

Activity by Year

2020-2021 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 18 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

F. Ay

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Transcriptional Control of Brain Tumour Stem Cell by a Carbohydrate Binding Protein

A. Sharanek, A. Burban, A. Hernandez-Corchado, A. Madrigal, I. Fatakdawala, H. S. Najafabadi, V. D. Soleimani, A. Jahani-Asl

This study identifies LGALS1 as a key regulator of brain tumour stem cells and glioblastoma resistance, showing its role in self-renewal, tumourigenesis, and response to radiation.

bioRxiv · Apr 14, 2021Cancer Biology

COVID-19 genetic risk variants are associated with expression of multiple genes in diverse immune cell types.

B. J. Schmiedel, V. Chandra, J. Rocha, C. Gonzalez-Colin, S. Bhattacharyya, A. Madrigal, C. H. Ottensmeier, F. Ay, P. Vijayanand

The paper identifies COVID-19 risk variants associated with gene expression in multiple immune cell types, revealing potential mechanisms linking genetic risk to disease severity.

bioRxiv · Dec 1, 2020Immunology

CD4+ follicular helper-like T cells are key players in anti-tumor immunity

D. Singh, A. P. Ganesan, B. Panwar, S. Eschweiler, C. Hanley, A. Madrigal, C. Ramirez Suastegui, A. Wang, J. Clarke, O. Wood, E. M. Garrido-Martin, S. Chee, G. Seumois, S. Belanger, A. Alzetani, , P. Vijayanand

The paper identifies CD4+ follicular helper-like T cells as critical for enhancing anti-tumor CD8+ T cell responses and tumor growth inhibition.

bioRxiv · Jan 8, 2020 · PreprintImmunology